180 related articles for article (PubMed ID: 15800661)
1. Transcriptional targeting of acute hypoxia in the tumour stroma is a novel and viable strategy for cancer gene therapy.
Ingram N; Porter CD
Gene Ther; 2005 Jul; 12(13):1058-69. PubMed ID: 15800661
[TBL] [Abstract][Full Text] [Related]
2. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS
Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966
[TBL] [Abstract][Full Text] [Related]
3. A tumor-specific gene therapy strategy targeting dysregulation of the VHL/HIF pathway in renal cell carcinomas.
Ogura M; Shibata T; Yi J; Liu J; Qu R; Harada H; Hiraoka M
Cancer Sci; 2005 May; 96(5):288-94. PubMed ID: 15904470
[TBL] [Abstract][Full Text] [Related]
4. Development of a hypoxia-responsive vector for tumor-specific gene therapy.
Shibata T; Giaccia AJ; Brown JM
Gene Ther; 2000 Mar; 7(6):493-8. PubMed ID: 10757022
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia- and radiation-inducible, breast cell-specific targeting of retroviral vectors.
Lipnik K; Greco O; Scott S; Knapp E; Mayrhofer E; Rosenfellner D; Günzburg WH; Salmons B; Hohenadl C
Virology; 2006 May; 349(1):121-33. PubMed ID: 16464484
[TBL] [Abstract][Full Text] [Related]
6. A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component.
Emiliusen L; Gough M; Bateman A; Ahmed A; Voellmy R; Chester J; Diaz RM; Harrington K; Vile R
Gene Ther; 2001 Jul; 8(13):987-98. PubMed ID: 11438833
[TBL] [Abstract][Full Text] [Related]
7. A noninvasive approach for assessing tumor hypoxia in xenografts: developing a urinary marker for hypoxia.
Nelson DW; Cao H; Zhu Y; Sunar-Reeder B; Choi CY; Faix JD; Brown JM; Koong AC; Giaccia AJ; Le QT
Cancer Res; 2005 Jul; 65(14):6151-8. PubMed ID: 16024616
[TBL] [Abstract][Full Text] [Related]
8. A novel adenoviral vector which mediates hypoxia-inducible gene expression selectively in neurons.
Huang D; Desbois A; Hou ST
Gene Ther; 2005 Sep; 12(18):1369-76. PubMed ID: 15843806
[TBL] [Abstract][Full Text] [Related]
9. [Oncostatin M gene therapy in mice bearing lung adenocarcinoma xenograft using a hypoxia/radiation dual-sensitive promoter].
Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):240-3. PubMed ID: 15144614
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
Greco O; Joiner MC; Doleh A; Powell AD; Hillman GG; Scott SD
Gene Ther; 2006 Feb; 13(3):206-15. PubMed ID: 16307003
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia response element-driven cytosine deaminase/5-fluorocytosine gene therapy system: a highly effective approach to overcome the dynamics of tumour hypoxia and enhance the radiosensitivity of prostate cancer cells in vitro.
Marignol L; Foley R; Southgate TD; Coffey M; Hollywood D; Lawler M
J Gene Med; 2009 Feb; 11(2):169-79. PubMed ID: 19051213
[TBL] [Abstract][Full Text] [Related]
12. Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers.
Modlich U; Pugh CW; Bicknell R
Gene Ther; 2000 May; 7(10):896-902. PubMed ID: 10845728
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis, necrosis and hypoxia inducible factor-1 in human head and neck squamous cell carcinoma cultures.
Gross J; Fuchs J; Machulik A; Jahnke V; Kietzmann T; Bockmühl U
Int J Oncol; 2005 Sep; 27(3):807-14. PubMed ID: 16077932
[TBL] [Abstract][Full Text] [Related]
14. Retroviral hybrid LTR vector strategy: functional analysis of LTR elements and generation of endothelial cell specificity.
Richardson TB; Kaspers J; Porter CD
Gene Ther; 2004 May; 11(9):775-83. PubMed ID: 14999228
[TBL] [Abstract][Full Text] [Related]
15. Small interfering RNA expression vector targeting hypoxia-inducible factor 1 alpha inhibits tumor growth in hepatobiliary and pancreatic cancers.
Mizuno T; Nagao M; Yamada Y; Narikiyo M; Ueno M; Miyagishi M; Taira K; Nakajima Y
Cancer Gene Ther; 2006 Feb; 13(2):131-40. PubMed ID: 16096651
[TBL] [Abstract][Full Text] [Related]
16. Heat-directed gene targeting of adenoviral vectors to tumor cells.
Brade AM; Ngo D; Szmitko P; Li PX; Liu FF; Klamut HJ
Cancer Gene Ther; 2000 Dec; 7(12):1566-74. PubMed ID: 11228535
[TBL] [Abstract][Full Text] [Related]
17. Generation of a high titre retroviral vector for endothelial cell-specific gene expression in vivo.
Mavria G; Jäger U; Porter CD
Gene Ther; 2000 Mar; 7(5):368-76. PubMed ID: 10694818
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologically regulated production of targeted retrovirus from T cells for systemic antitumor gene therapy.
Crittenden M; Gough M; Chester J; Kottke T; Thompson J; Ruchatz A; Clackson T; Cosset FL; Chong H; Diaz RM; Harrington K; Alvarez Vallina L; Vile R
Cancer Res; 2003 Jun; 63(12):3173-80. PubMed ID: 12810645
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging.
Hung SC; Deng WP; Yang WK; Liu RS; Lee CC; Su TC; Lin RJ; Yang DM; Chang CW; Chen WH; Wei HJ; Gelovani JG
Clin Cancer Res; 2005 Nov; 11(21):7749-56. PubMed ID: 16278396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]